⌘K

16:05:00·1367d

PRReleasevia Quantisnow

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.

CORT· Corcept Therapeutics Incorporated

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

CORT
Corcept Therapeutics Incorporated
Health Care

Recent analyst ratings

Mar 26UpdateWolfe Research-
Dec 31UpdateWolfe Research$30.00
Dec 16UpdateUBS-
Nov 18UpdateWolfe Research-
Nov 6UpdateTruist$38.00
Apr 11UpdateSVB Securities$25.00

Related

SEC18h
SEC Form 144 filed by Corcept Therapeutics Incorporated
SEC1d
SEC Form 10-Q filed by Corcept Therapeutics Incorporated
SEC1d
Corcept Therapeutics Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
PR1d
Corcept Phase 2 Study of Dazucorilant Demonstrates Two-Year Overall Survival Benefit in Patients with Amyotrophic Lateral Sclerosis
PR1d
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
INSIDER7d
Director Wilson James N gifted 2,000 shares (SEC Form 4)
PR8d
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
SEC10d
Amendment: SEC Form SCHEDULE 13G/A filed by Corcept Therapeutics Incorporated